Recombinant human TSH use in differentiated thyroid cancer
Traditionally, the immediate treatment of patients with differentiated thyroid carcinoma (DTC) after total thyroidectomy (TT) is thyroid remnant ablation (TRA) with131I, during hypothyroidism. Late follow-up of DCT includes suppressive doses of T4, serial measurements of thyroglobulin (Tg), whole body scan (WBS) with131I and cervical ultrasound (US). In the last years, TRA with the aid of recombinant human TSH (rhTSH) has shown not only to avoid symptoms of hypothyroidism and a lower quality of...[Show more]
|Collections||ANU Research Publications|
|Source:||Arquivos Brasileiros de Endocrinologia e Metabologia|
|01_Graf_Recombinant_human_TSH_use_in_2007.pdf||78.4 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.